Report overview
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
This report aims to provide a comprehensive presentation of the global market for Opioids Agonist Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids Agonist Drugs. This report contains market size and forecasts of Opioids Agonist Drugs in global, including the following market information:
Global Opioids Agonist Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Opioids Agonist Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Opioids Agonist Drugs companies in 2022 (%)
The global Opioids Agonist Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
We surveyed the Opioids Agonist Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioids Agonist Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Type, 2022 (%)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Global Opioids Agonist Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Application, 2022 (%)
Pain Management
Cough Treatment
Diarrhea Treatment
Global Opioids Agonist Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioids Agonist Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Opioids Agonist Drugs revenues share in global market, 2022 (%)
Key companies Opioids Agonist Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Opioids Agonist Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opioids Agonist Drugs, market overview.
Chapter 2: Global Opioids Agonist Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Opioids Agonist Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioids Agonist Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Opioids Agonist Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
